COVID-19 Virtual Care at Home

NCT ID: NCT04420182

Last Updated: 2022-04-07

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 817 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2020-08-17
• Study Completion Date: 2022-02-04

Brief Summary

This multicentre prospective cohort trial is designed to demonstrate effectiveness and efficiency of a virtual care model for the management of COVID-19 patients isolating at home. The investigators have reoriented existing technology and networks for this research project. The investigators are amplifying our existing virtual care platform VIRTUES, combining it with home monitoring of COVID-19 patients, to provide real-time evidence, harmonize data collection, and share data provincially to mitigate the impact of the rapid spread of the virus. The study will facilitate early detection of complications associated with the disease, treatment and management of COVID-19 patients at home. The research will be conducted provincially in Ontario.

This initiative will provide evidence to inform clinical and health system management and public health response to COVID-19 patients isolating at home.

Conditions

Covid-19

Study Design

• Allocation Method: NA
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: TREATMENT
• Blinding Strategy: NONE

Study Groups

COVID-19 Virtual Care at Home

VIRTUES COVID-19 Care at Home Platform

The components of the platform will include:

1. Vital sign monitoring, including O2 saturation with a home-based pulse oximeter, temperature and respiratory rate performed three times per day (a notification to do this will be sent from the app), with the option of doing assessments more frequently if needed. Study patients will be provided monitoring devices to collect this data.

2. Symptom logs will be entered by the patients.

3. Feedback to the patient by the local COVID-19 care team for any action:

1. Two-way communication between the patient and the COVID-19 care team

2. Ability for team members to see all prior notes in order to have continuity of care

3. Reports of these interactions are transmitted to the patient's health record

4. Current information on COVID-19 as per the Public Health Agency of Canada

Group Type: OTHER

Virtual Care at Home

Intervention Type: OTHER

Participants will have access to the VIRTUES platform for COVID-19 Virtual Care at Home

Interventions

Virtual Care at Home

Participants will have access to the VIRTUES platform for COVID-19 Virtual Care at Home

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• All COVID-19 positive patients of age 18 or above
• Participant must communicate in English or French language
• An email address and account

Exclusion Criteria

• Unable or unwilling to provide informed consent

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Cardiac Arrhythmia Network of Canada

OTHER

Sponsor Role: collaborator

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER

Sponsor Role: lead

Responsible Party

Anthony Tang

Principal Investigator

Responsibility Role: PRINCIPAL_INVESTIGATOR

Locations

St. Mary's General Hospital

Kitchener, Ontario, Canada

London Health Sciences Centre

London, Ontario, Canada

Ottawa Heart Research Institute

Ottawa, Ontario, Canada

Niagara Health

St. Catharines, Ontario, Canada

St. Joseph's Health Centre

Toronto, Ontario, Canada

Countries

Canada

Other Identifiers

CTO 3210

Identifier Type: -

Identifier Source: org_study_id